Susquehanna International Group’s Turnstone Biologics TSBX Stock Holding History

Susquehanna International Group’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-79,305	Closed	-$28.5K	–	13920
2025 Q2	$28.5K	Buy	79,305 +54,000	+213%	+$18.9K	﹤0.01%	12262
2025 Q1	$10.4K	Sell	25,305 -42,019	-62%	-$17.9K	﹤0.01%	12210
2024 Q4	$33.3K	Buy	+67,324	New	+$33.3K	﹤0.01%	11815
2024 Q3	–	Sell	-51,293	Closed	-$134K	–	13062
2024 Q2	$134K	Buy	51,293 +27,922	+119%	+$79.8K	﹤0.01%	10805
2024 Q1	$61.2K	Buy	+23,371	New	+$66.9K	﹤0.01%	11472

Susquehanna International Group's TSBX Position: Q3 2025 in Review

Susquehanna International Group sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 79,305 shares — an estimated $28.5K sold.

Susquehanna International Group first reported a position in TSBX in Q1 2024 and held it in 5 quarters. The position peaked at $134K in Q2 2024. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

Susquehanna International Group reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 79,305 Turnstone Biologics shares in Q3 2025, an estimated $28.5K.
Susquehanna International Group first reported a position in Turnstone Biologics in Q1 2024 and held it in 5 quarters.
Susquehanna International Group's Turnstone Biologics position peaked at $134K in Q2 2024.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.